![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pfizer Recalls Blood Pressure Drug Accuretic in UK Due to Nitrosamine Risk
Pfizer Recalls Blood Pressure Drug Accuretic in UK Due to Nitrosamine Risk
Pfizer has recalled a single batch of its blood pressure drug, Accuretic (quinapril HCl/hydrochlorothiazide), in the UK following the detection of a nitrosamine contaminant, N-nitroso-quinapril, at levels above the acceptable limit.
The batch of concern, numbered DD4842, was for quinapril HCl 10 mg/ hydrochlorothiazide 12.5 mg film-coated tablets distributed in April 2020.
Consumption of nitrosamine at amounts above acceptable levels long-term could lead to an increased risk of cancer.
The recall will affect Accuretic supply at the wholesaler and pharmacy levels, the company said.
Upcoming Events
-
21Oct